• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise
  • Microbiome Job Board

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

April 15, 2022 Laurence Zitvogel Editor's Choice, Pharma & Human Health

 

Laurence Zitvogel
Group Leader of Tumour immunology and immunotherapy of cancer at Institut Gustave Roussy

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers
    April 15, 2022
  • Did you miss Probiota Copenhagen 2022? Catch up now!
    April 12, 2022
  • A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology
    February 18, 2022
  • Protecting and Preserving the Intestinal Microbiome from Antibiotic-induced Dysbiosis with DAV132
    February 17, 2022
  • ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
    February 7, 2022
sign up

Sign up to the Microbiome Times newsletterÂ